Trials / Sponsors / EyeGene Inc.
EyeGene Inc.
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years O Meningococcal Infections | Phase 2 / Phase 3 | 2025-10-15 |
| Completed | Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult COVID-19 | Phase 1 / Phase 2 | 2023-11-30 |
| Completed | Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy A COVID-19 Vaccine | Phase 1 / Phase 2 | 2022-03-22 |
| Completed | Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers Prevention of Herpes Zoster (HZ) | Phase 1 | 2020-02-24 |